Jessica Perl's most recent trade in Emergent Biosolutions Inc was a trade of 62,500 Common Stock done . Disclosure was reported to the exchange on March 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc | Jessica Perl | SVP, General Counsel, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 68,387 (0%) | 0% | 0 | Common Stock | |
Emergent Biosolutions Inc | Jessica Perl | SVP, General Counsel, Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 95,945 | - | - | Employee Stock Options (Right to Buy) | |
Emergent Biosolutions Inc | Jessica Perl | SVP, General Counsel, Corp Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.00 per share. | 09 Feb 2025 | 918 | 5,887 (0%) | 0% | 10 | 9,180 | Common Stock |